Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias A Oberli

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Organic Letters|August 17, 2012
A general method for Suzuki-Miyaura coupling reactions using lithium triisopropyl boratesMatthias A Oberli, Stephen L Buchwald
Organic Letters|August 28, 2004
Diradical-promoted (N + 2 - 1) ring expansion: an efficient reaction for the synthesis of macrocyclic ketonesGeorg Rüedi, Matthias A Oberli, Matthias Nagel, et al.
Therapeutic Delivery|October 8, 2014
Ultrasound-enhanced transdermal delivery: recent advances and future challengesMatthias A Oberli, Carl M Schoellhammer, Robert Langer, et al.
Organic Letters|February 1, 2008
Synthesis of a hexasaccharide repeating unit from Bacillus anthracis vegetative cell wallsMatthias A Oberli, Pascal Bindschädler, Daniel B Werz, et al.
Therapeutic Delivery|April 15, 2016
mRNA vaccine delivery using lipid nanoparticlesAndreas M Reichmuth, Matthias A Oberli, Ana Jaklenec, et al.
Chemistry & Biology|May 26, 2011
A possible oligosaccharide-conjugate vaccine candidate for Clostridium difficile is antigenic and immunogenicMatthias A Oberli, Marie-Lyn Hecht, Pascal Bindschädler, et al.
Journal of the American Chemical Society|June 26, 2013
Immunological evaluation of a synthetic Clostridium difficile oligosaccharide conjugate vaccine candidate and identification of a minimal epitopeChristopher E Martin, Felix Broecker, Matthias A Oberli, et al.
Chemical Communications (Cambridge, England)|July 10, 2013
Glycan arrays containing synthetic Clostridium difficile lipoteichoic acid oligomers as tools toward a carbohydrate vaccineChristopher E Martin, Felix Broecker, Steffen Eller, et al.
Nano Letters|March 10, 2017
Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer ImmunotherapyMatthias A Oberli, Andreas M Reichmuth, J Robert Dorkin, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|October 20, 2010
Surface characterization of carbohydrate microarraysDavid J Scurr, Tim Horlacher, Matthias A Oberli, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Organic Letters|August 17, 2012
A general method for Suzuki-Miyaura coupling reactions using lithium triisopropyl boratesMatthias A Oberli, Stephen L Buchwald
Organic Letters|August 28, 2004
Diradical-promoted (N + 2 - 1) ring expansion: an efficient reaction for the synthesis of macrocyclic ketonesGeorg Rüedi, Matthias A Oberli, Matthias Nagel, et al.
Therapeutic Delivery|October 8, 2014
Ultrasound-enhanced transdermal delivery: recent advances and future challengesMatthias A Oberli, Carl M Schoellhammer, Robert Langer, et al.
Organic Letters|February 1, 2008
Synthesis of a hexasaccharide repeating unit from Bacillus anthracis vegetative cell wallsMatthias A Oberli, Pascal Bindschädler, Daniel B Werz, et al.
Therapeutic Delivery|April 15, 2016
mRNA vaccine delivery using lipid nanoparticlesAndreas M Reichmuth, Matthias A Oberli, Ana Jaklenec, et al.
Chemistry & Biology|May 26, 2011
A possible oligosaccharide-conjugate vaccine candidate for Clostridium difficile is antigenic and immunogenicMatthias A Oberli, Marie-Lyn Hecht, Pascal Bindschädler, et al.
Journal of the American Chemical Society|June 26, 2013
Immunological evaluation of a synthetic Clostridium difficile oligosaccharide conjugate vaccine candidate and identification of a minimal epitopeChristopher E Martin, Felix Broecker, Matthias A Oberli, et al.
Chemical Communications (Cambridge, England)|July 10, 2013
Glycan arrays containing synthetic Clostridium difficile lipoteichoic acid oligomers as tools toward a carbohydrate vaccineChristopher E Martin, Felix Broecker, Steffen Eller, et al.
Nano Letters|March 10, 2017
Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer ImmunotherapyMatthias A Oberli, Andreas M Reichmuth, J Robert Dorkin, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|October 20, 2010
Surface characterization of carbohydrate microarraysDavid J Scurr, Tim Horlacher, Matthias A Oberli, et al.
Pageof 2